Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these biomedical...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Acceso en liña: | https://doi.org/10.1371/journal.pone.0250780 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
